<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9032271" created="07/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9032271</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Characterization of a <term id="T1" lex="mutant_cell_line" sem="Cell_cultured">mutant cell line</term> that does not activate <term id="T2" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in response to <term id="A1" sem="Other">multiple stimuli</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<cause idref="A1"/>
<clue>Characterization of a <clueLoc>mutant cell line</clueLoc> that does <cluePolarity>not</cluePolarity> <clueType>activate</clueType> NF-kappaB <linkCause>in response to</linkCause> multiple stimuli.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="A3" sem="DNA_domain_or_region">Numerous genes</term> required during the <cons id="C2" lex="(OR immune_response inflammation_response)" sem="(OR Other Other)"><frag id="F11">immune</frag> or <frag id="F12">inflammation</frag> <frag id="F13">response</frag></cons> as well as the <term id="A4" sem="Other">adhesion process</term> are regulated by <term id="T4" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T5" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>).</sentence>
<event KT="Other" id="E2">
<type class="Regulation"/>
<theme idref="F11" idref1="F13"/>
<cause idref="A3"/>
<clue>Numerous genes <clueType>required</clueType> <linkTheme>during</linkTheme> the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB).</clue>
</event>
<event KT="Other" id="E148">
<type class="Regulation"/>
<theme idref="F12" idref1="F13"/>
<cause idref="A3"/>
<clue>Numerous genes <clueType>required</clueType> <linkTheme>during</linkTheme> the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB).</clue>
</event>
<event KT="Other" id="E3">
<type class="Regulation"/>
<theme idref="A4"/>
<cause idref="A3"/>
<clue>Numerous genes <clueType>required</clueType> <linkTheme>during</linkTheme> the immune or inflammation response as well as the adhesion process are regulated by nuclear factor kappaB (NF-kappaB).</clue>
</event>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="A3"/>
<cause idref="T15"/>
<clue>Numerous genes required during the immune or inflammation response as well as the adhesion process are <clueType>regulated</clueType> <linkCause>by</linkCause> nuclear factor kappaB (NF-kappaB).</clue>
</event>
<sentence id="S3">Associated with its inhibitor, <term id="T6" lex="I_kappaB" sem="Protein_molecule">I kappaB</term>, <term id="T7" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> resides as an inactive form in the <term id="T8" lex="cytoplasm" sem="Cell_component">cytoplasm</term>.</sentence>
<event KT="Fact" id="E5">
<type class="Binding"/>
<theme idref="T6"/>
<theme idref="T7"/>
<clue><clueType>Associated</clueType> <linkTheme>with</linkTheme> its inhibitor, I kappaB, NF-kappaB resides as an inactive form in the cytoplasm.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Negative_regulation"/>
<theme idref="T7"/>
<cause idref="E5"/>
<clue>Associated with its inhibitor, I kappaB, NF-kappaB <clueType>resides</clueType> as an <clueType>inactive form</clueType> <clueLoc>in the cytoplasm</clueLoc>.</clue>
</event>
<sentence id="S4">Upon stimulation by <term id="A5" sem="Other">various agents</term>, <term id="T9" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> is proteolyzed and <term id="T10" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> translocates to the nucleus, where it activates <term id="A6" sem="DNA_domain_or_region">its target genes</term>.</sentence>
<event KT="Fact" id="E7">
<type class="Protein_catabolism"/>
<theme idref="T9"/>
<clue>Upon stimulation by various agents, I kappaB is <clueType>proteolyzed</clueType> and NF-kappaB translocates to the nucleus, where it activates its target genes.</clue>
</event>
<event KT="Method" id="E8">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="A5"/>
<clue><clueType>Upon stimulation</clueType> <linkCause>by</linkCause> various agents, I kappaB is proteolyzed and NF-kappaB translocates to the nucleus, where it activates its target genes.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Localization"/>
<theme idref="T10"/>
<clue>Upon stimulation by various agents, I kappaB is proteolyzed and NF-kappaB <clueType>translocates</clueType> <clueLoc>to the nucleus</clueLoc>, where it activates its target genes.</clue>
</event>
<event KT="Method" id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="A5"/>
<clue><clueType>Upon stimulation</clueType> <linkCause>by</linkCause> various agents, I kappaB is proteolyzed and NF-kappaB translocates to the nucleus, where it activates its target genes.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="T10"/>
<clue>Upon stimulation by various agents, I kappaB is proteolyzed and NF-kappaB translocates to the <clueLoc>nucleus</clueLoc>, where <corefCause>it</corefCause> activates its target genes.</clue>
</event>
<sentence id="S5">The <term id="T11" lex="transduction_pathway" sem="Other">transduction pathways</term> that lead to <term id="T12" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> inactivation remain poorly understood.</sentence>
<event KT="Other" id="E12">
<type class="Negative_regulation"/>
<theme idref="T12"/>
<clue>The transduction pathways that lead to I kappaB <clueType>inactivation</clueType> remain poorly understood.</clue>
</event>
<event KT="Fact" id="E48">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T11"/>
<clue>The transduction pathways that <clueType>lead</clueType> <linkTheme>to</linkTheme> I kappaB inactivation remain poorly understood.</clue>
</event>
<sentence id="S6">In this study, we have characterized a cellular mutant, the <term id="T13" lex="70/Z3-derived_1.3E2_murine_pre-B_cell_line" sem="Cell_cultured">70/Z3-derived 1.3E2 murine pre-B cell line</term>, that does not activate <term id="T14" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in response to <term id="A7" sem="Other">several stimuli</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E13">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<cause idref="A7"/>
<clue>In this study, we have characterized a cellular mutant, <clueLoc>the 70/Z3-derived 1.3E2 murine pre-B cell line</clueLoc>, that does <cluePolarity>not</cluePolarity> <clueType>activate</clueType> NF-kappaB <linkCause>in response to</linkCause> several stimuli.</clue>
</event>
<sentence id="S7">We demonstrate that upon stimulation by <term id="T15" lex="lipopolysaccharide" sem="Lipid">lipopolysaccharide</term>, <term id="T16" lex="Taxol" sem="Organic_compound_other">Taxol</term>, <term id="T17" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term>, <term id="T18" lex="interleukin-1" sem="Protein_molecule">interleukin-1</term>, or <term id="T19" lex="double-stranded_RNA" sem="RNA_family_or_group">double-stranded RNA</term>, <term id="T20" lex="I_kappaB_alpha" sem="Protein_molecule"><term id="T21" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> alpha</term> is not degraded, as a result of an absence of induced phosphorylation on <cons id="T22" lex="(AND serine_32 serine_36)" sem="(AND Amino_acid_monomer Amino_acid_monomer)"><frag id="F1">serines</frag> <frag id="F2">32</frag> and <frag id="F3">36</frag></cons>.</sentence>
<event KT="Method" id="E14">
<type class="Physiological_process"/>
<theme idref="T13"/>
<cause idref="T15"/>
<clue>We demonstrate that upon <clueType>stimulation</clueType> <linkCause>by</linkCause> lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36.</clue>
<comment>No coref Theme</comment></event>
<event KT="Method" id="E15">
<type class="Physiological_process"/>
<theme idref="T13"/>
<cause idref="T16"/>
<clue>We demonstrate that upon <clueType>stimulation</clueType> <linkCause>by</linkCause> lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36.</clue>
<comment>No corefTheme</comment></event>
<event KT="Method" id="E16">
<type class="Physiological_process"/>
<theme idref="T13"/>
<cause idref="T17"/>
<clue>We demonstrate that upon <clueType>stimulation</clueType> <linkCause>by</linkCause> lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36.</clue>
<comment>No corefTheme</comment></event>
<event KT="Method" id="E17">
<type class="Physiological_process"/>
<theme idref="T13"/>
<cause idref="T18"/>
<clue>We demonstrate that upon <clueType>stimulation</clueType> <linkCause>by</linkCause> lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36.</clue>
<comment>No corefTheme</comment></event>
<event KT="Method" id="E18">
<type class="Physiological_process"/>
<theme idref="T13"/>
<cause idref="T19"/>
<clue>We demonstrate that upon <clueType>stimulation</clueType> <linkCause>by</linkCause> lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced phosphorylation on serines 32 and 36.</clue>
<comment>No corefTheme</comment></event>
<event KT="Other" id="E19">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T20"/>
<site idref="F1" idref1="F2"/>
<site idref="F1" idref1="F3"/>
<clue>We demonstrate that upon stimulation by lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an absence of induced <clueType>phosphorylation</clueType> on serines 32 and 36.</clue>
<comment>No corefTheme</comment></event>
<event KT="Other" id="E20">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<clue>We demonstrate that upon stimulation by lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is not degraded, as a result of an <clueType>absence</clueType> <linkTheme>of</linkTheme> induced phosphorylation on serines 32 and 36.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E21">
<type class="Protein_catabolism"/>
<theme idref="T20"/>
<cause idref="E20"/>
<clue>We <clueKT>demonstrate</clueKT> that upon stimulation by lipopolysaccharide, Taxol, phorbol myristate acetate, interleukin-1, or double-stranded RNA, I kappaB alpha is <cluePolarity>not</cluePolarity> <clueType>degraded</clueType>, <linkCause>as a result of</linkCause> an absence of induced phosphorylation on serines 32 and 36.</clue>
</event>
<sentence id="S8">Neither a mutation in <term id="T23" lex="I_kappaB_alpha" sem="Protein_molecule"><term id="T24" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> alpha</term> nor a mutation in <term id="T25" lex="p50" sem="Protein_molecule">p50</term> or <term id="T26" lex="relA" sem="Protein_molecule">relA</term>, the two major subunits of <term id="T27" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in this cell line, accounts for this <term id="T28" lex="phosphorylation_defect" sem="Other">phosphorylation defect</term>.</sentence>
<event KT="Method" id="E22">
<type class="Mutagenesis"/>
<theme idref="T23"/>
<clue>Neither a <clueType>mutation</clueType> <linkTheme>in</linkTheme> I kappaB alpha nor a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, accounts for this phosphorylation defect.</clue>
<comment>ARTIFICIAL</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E23">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="E22"/>
<clue><cluePolarity>Neither</cluePolarity> a mutation in I kappaB alpha nor a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, <clueType>accounts for</clueType> <corefTheme>this phosphorylation defect</corefTheme>.</clue>
</event>
<event KT="Method" id="E24">
<type class="Mutagenesis"/>
<theme idref="T25"/>
<clue>Neither a mutation in I kappaB alpha nor a <clueType>mutation</clueType> <linkTheme>in</linkTheme> p50 or relA, the two major subunits of NF-kappaB in this cell line, accounts for this phosphorylation defect.</clue>
<comment>ARTIFICIAL</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="E24"/>
<clue>Neither a mutation in I kappaB alpha <cluePolarity>nor</cluePolarity> a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, <clueType>accounts for</clueType> <corefTheme>this phosphorylation defect</corefTheme>.</clue>
</event>
<event KT="Method" id="E26">
<type class="Mutagenesis"/>
<theme idref="T26"/>
<clue>Neither a mutation in I kappaB alpha nor a <clueType>mutation</clueType> <linkTheme>in</linkTheme> p50 or relA, the two major subunits of NF-kappaB in this cell line, accounts for this phosphorylation defect.</clue>
<comment>ARTIFICIAL</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E125">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="E26"/>
<clue>Neither a mutation in I kappaB alpha <cluePolarity>nor</cluePolarity> a mutation in p50 or relA, the two major subunits of NF-kappaB in this cell line, <clueType>accounts for</clueType> <corefTheme>this phosphorylation defect</corefTheme>.</clue>
</event>
<sentence id="S9">As well as culminating in the <term id="T29" lex="inducible_phosphorylation" sem="Other">inducible phosphorylation</term> of <term id="T30" lex="I_kappaB" sem="Protein_molecule">I kappaB alpha</term> on <cons id="T31" lex="(AND serine_32 serine_36)" sem="(AND Amino_acid_monomer Amino_acid_monomer)"><frag id="F4"><term id="A68" sem="Amino_acid_monomer">serines</term></frag> <frag id="F5"><term id="A69" sem="Amino_acid_monomer">32</term></frag> and <frag id="F6"><term id="A70" sem="Amino_acid_monomer">36</term></frag></cons>, all the stimuli that are inactive on <term id="T32" lex="1.3E2_cell" sem="Cell_cultured">1.3E2 cells</term> exhibit a sensitivity to the <term id="T33" lex="antioxidant" sem="Organic_compound_other">antioxidant</term> <term id="T34" lex="pyrrolidine_dithiocarbamate" sem="Organic_compound_other">pyrrolidine dithiocarbamate</term> (<term id="T35" lex="PDTC" sem="Organic_compound_other">PDTC</term>).</sentence>
<event id="E126">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T30"/>
<site idref="A68" idref1="A69"/>
<site idref="A68" idref1="A70"/>
<clue>As well as culminating in the inducible <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> I kappaB alpha on serines 32 and 36, all the stimuli that are inactive on 1.3E2 cells exhibit a sensitivity to the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
<comment>NER T30 MOD</comment></event>
<event id="E326">
<type class="Positive_regulation"/>
<theme idref="E126"/>
<clue>As well as <clueType>culminating</clueType> <linkTheme>in</linkTheme> the inducible phosphorylation of I kappaB alpha on serines 32 and 36, all the stimuli that are inactive on 1.3E2 cells exhibit a sensitivity to the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
</event>
<event id="E27">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="T35"/>
<clue>As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, <corefTheme>all the stimuli</corefTheme> that are inactive on 1.3E2 cells <clueType><clueKT>exhibit</clueKT> a sensitivity</clueType> <linkCause>to</linkCause> the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
<comment>SENSITIVITY</comment></event>
<event id="E28">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="T35"/>
<clue>As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, <corefTheme>all the stimuli</corefTheme> that are inactive on 1.3E2 cells <clueType><clueKT>exhibit</clueKT> a sensitivity</clueType> <linkCause>to</linkCause> the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
<comment>SENSITIVITY</comment></event>
<event id="E29">
<type class="Regulation"/>
<theme idref="E16"/>
<cause idref="T35"/>
<clue>As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, <corefTheme>all the stimuli</corefTheme> that are inactive on 1.3E2 cells <clueType><clueKT>exhibit</clueKT> a sensitivity</clueType> <linkCause>to</linkCause> the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
<comment>SENSITIVITY</comment></event>
<event id="E30">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="T35"/>
<clue>As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, <corefTheme>all the stimuli</corefTheme> that are inactive on 1.3E2 cells <clueType><clueKT>exhibit</clueKT> a sensitivity</clueType> <linkCause>to</linkCause> the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
<comment>SENSITVITY</comment></event>
<event id="E31">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="T35"/>
<clue>As well as culminating in the inducible phosphorylation of I kappaB alpha on serines 32 and 36, <corefTheme>all the stimuli</corefTheme> that are inactive on 1.3E2 cells <clueType><clueKT>exhibit</clueKT> a sensitivity</clueType> <linkCause>to</linkCause> the antioxidant pyrrolidine dithiocarbamate (PDTC).</clue>
<comment>SENSITIVITY</comment></event>
<sentence id="S10">In contrast, stimuli such as <term id="T36" lex="hyperosmotic_shock" sem="Other">hyperosmotic shock</term> or <term id="T37" lex="phosphatase_inhibitor" sem="Organic_compound_other">phosphatase inhibitors</term>, which use <term id="T38" lex="PDTC-insensitive_pathway" sem="Other"><term id="T39" lex="PDTC" sem="Organic_compound_other">PDTC</term>-insensitive pathways</term>, induce <term id="T40" lex="I_kappaB" sem="Protein_molecule">I kappaB alpha</term> degradation in <term id="T41" lex="1.3E2" sem="Cell_cultured">1.3E2</term>.</sentence>
<event Polarity="Negative" assertion="non-exist" id="E53">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T36"/>
<clue>In contrast, <corefCause>stimuli</corefCause> such as hyperosmotic shock or phosphatase inhibitors, which <clueType>use</clueType> PDTC-<cluePolarity>insensitive</cluePolarity> pathways, induce I kappaB alpha degradation in 1.3E2.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E54">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T37"/>
<clue>In contrast, <corefCause>stimuli</corefCause> such as hyperosmotic shock or phosphatase inhibitors, which <clueType>use</clueType> PDTC-<cluePolarity>insensitive</cluePolarity> pathways, induce I kappaB alpha degradation in 1.3E2.</clue>
</event>
<event id="E34">
<type class="Protein_catabolism"/>
<theme idref="T40"/>
<clue>In contrast, stimuli such as hyperosmotic shock or phosphatase inhibitors, which use PDTC-insensitive pathways, induce I kappaB alpha <clueType>degradation</clueType> in 1.3E2.</clue>
<comment>NER T40 mod</comment></event>
<event id="E35">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="T36"/>
<clue>In contrast, stimuli such as hyperosmotic shock or phosphatase inhibitors, which use PDTC-insensitive pathways, <clueType>induce</clueType> I kappaB alpha degradation <clueLoc>in 1.3E2</clueLoc>.</clue>
</event>
<event id="E36">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="T37"/>
<clue>In contrast, stimuli such as hyperosmotic shock or phosphatase inhibitors, which use PDTC-insensitive pathways, <clueType>induce</clueType> I kappaB alpha degradation <clueLoc>in 1.3E2</clueLoc>.</clue>
</event>
<sentence id="S11">Analysis of the redox status of <term id="T42" lex="1.3E2" sem="Cell_cultured">1.3E2</term> does not reveal any difference from <term id="T43" lex="wild-type_70Z/3" sem="Cell_cultured">wild-type 70Z/3</term>.</sentence>
<sentence id="S12">We also report that the <term id="T44" lex="human_T-cell_leukemia_virus_type_1_(HTLV-1)-derived_Tax_trans-activator" sem="Protein_molecule"><term id="T45" lex="human_T-cell_leukemia_virus_type_1" sem="Virus">human T-cell leukemia virus type 1</term> (<term id="T46" lex="HTLV-1" sem="Virus">HTLV-1</term>)-derived <term id="T47" lex="Tax" sem="Protein_molecule">Tax</term> trans-activator</term> induces <term id="T48" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activity in <term id="T49" lex="1.3E2" sem="Cell_cultured">1.3E2</term>, suggesting that this viral protein does not operate via the <term id="T50" lex="defective_pathway" sem="Other">defective pathway</term>.</sentence>
<event KT="Analysis" id="E37">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<cause idref="T47"/>
<clue>We also <clueKT>report</clueKT> that the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator <clueType>induces</clueType> NF-kappaB activity <clueLoc>in 1.3E2</clueLoc>, suggesting that this viral protein does not operate via the defective pathway.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E38">
<type class="Regulation"/>
<theme idref="E19"/>
<cause idref="T47"/>
<clue>We also report that the human T-cell leukemia virus type 1 (HTLV-1)-derived Tax trans-activator induces NF-kappaB activity in 1.3E2, <clueKT><clueCL>suggesting</clueCL></clueKT> that <corefCause>this viral protein</corefCause> does <cluePolarity>not</cluePolarity> <clueType>operate</clueType> <linkTheme>via</linkTheme> <corefTheme>the defective pathway</corefTheme>.</clue>
</event>
<sentence id="S13">Finally, we show that two other <term id="T51" lex="I_kappaB_molecule" sem="Protein_molecule"><term id="T52" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> molecules</term>, <term id="T53" lex="I_kappaB_beta" sem="Protein_molecule"><term id="T54" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> beta</term> and the recently identified <term id="T55" lex="I_kappaB_epsilon" sem="Protein_molecule"><term id="T56" lex="I_kappaB" sem="Protein_molecule">I kappaB</term> epsilon</term>, are not degraded in the <term id="T57" lex="1.3E2" sem="Cell_cultured">1.3E2</term> cell line following <term id="A8" sem="Other">stimulation</term>.</sentence>
<event KT="Analysis" Polarity="Negative" id="E39">
<type class="Protein_catabolism"/>
<theme idref="T53"/>
<clue>Finally, we <clueKT>show</clueKT> that <corefTheme>two other I kappaB molecules</corefTheme>, I kappaB beta and the recently identified I kappaB epsilon, are <cluePolarity>not</cluePolarity> <clueType>degraded</clueType> in the 1.3E2 cell line following stimulation.</clue>
</event>
<event KT="Analysis" Polarity="Negative" id="E40">
<type class="Protein_catabolism"/>
<theme idref="T55"/>
<clue>Finally, we <clueKT>show</clueKT> that <corefTheme>two other I kappaB molecules</corefTheme>, I kappaB beta and the recently identified I kappaB epsilon, are <cluePolarity>not</cluePolarity> <clueType>degraded</clueType> in the 1.3E2 cell line following stimulation.</clue>
</event>
<event KT="Other" assertion="non-exist" id="E41">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A8"/>
<clue>Finally, we show that two other I kappaB molecules, I kappaB beta and the recently identified I kappaB epsilon, are not degraded <clueLoc>in the 1.3E2 cell line</clueLoc> <clueType>following</clueType> stimulation.</clue>
</event>
<event KT="Other" assertion="non-exist" id="E42">
<type class="Positive_regulation"/>
<theme idref="E40"/>
<cause idref="A8"/>
<clue>Finally, we show that two other I kappaB molecules, I kappaB beta and the recently identified I kappaB epsilon, are not degraded <clueLoc>in the 1.3E2 cell line</clueLoc> <clueType>following</clueType> stimulation.</clue>
</event>
<sentence id="S14">Our results demonstrate that <term id="T58" lex="1.3E2" sem="Cell_cultured">1.3E2</term> is a <term id="T59" lex="cellular_transduction_mutant" sem="Protein_family_or_group">cellular transduction mutant</term> exhibiting a defect in a <term id="A9" sem="Other">step</term> that is required by <term id="A10" sem="Other">several different stimuli</term> to activate <term id="T60" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>.</sentence>
<event KT="Other" id="E43">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<cause idref="A10"/>
<clue>Our results demonstrate that 1.3E2 is a cellular transduction mutant exhibiting a defect in a step that is <clueType>required</clueType> <linkCause>by</linkCause> several different stimuli to activate NF-kappaB.</clue>
</event>
<event KT="Other" id="E44">
<type class="Positive_regulation"/>
<theme idref="T60"/>
<cause idref="E43"/>
<clue>Our results demonstrate that 1.3E2 is a cellular transduction mutant exhibiting a defect in a step that is required by several different stimuli to <clueType>activate</clueType> NF-kappaB.</clue>
</event>
<event KT="Analysis" id="E49">
<type class="Negative_regulation"/>
<theme idref="E44"/>
<clue>Our results <clueKT>demonstrate</clueKT> that <clueLoc>1.3E2</clueLoc> is a cellular transduction mutant exhibiting a <clueType>defect</clueType> <linkTheme>in</linkTheme> a step that is required by several different stimuli to activate NF-kappaB.</clue>
</event>
<sentence id="S15">In addition, this analysis suggests a common step in the <term id="A30" sem="Other">signaling pathways</term> that trigger <cons id="C1" lex="(AND I_kappaB_alpha_degradation I_kappaB_beta_degradation I_kappaB_epsilon_degradation)" sem="(AND Other Other Other)"><frag id="F7">I kappaB alpha</frag>, <frag id="F8">I kappaB beta</frag>, and <frag id="F9">I kappaB epsilon</frag> <frag id="F10">degradation</frag></cons>.</sentence>
<event KT="Other" id="E45">
<type class="Protein_catabolism"/>
<theme idref="F7"/>
<clue>In addition, this analysis suggests a common step in the signaling pathways that trigger I kappaB alpha, I kappaB beta, and I kappaB epsilon <clueType>degradation</clueType>.</clue>
</event>
<event KT="Other" id="E46">
<type class="Protein_catabolism"/>
<theme idref="F8"/>
<clue>In addition, this analysis suggests a common step in the signaling pathways that trigger I kappaB alpha, I kappaB beta, and I kappaB epsilon <clueType>degradation</clueType>.</clue>
</event>
<event KT="Other" id="E47">
<type class="Protein_catabolism"/>
<theme idref="F9"/>
<clue>In addition, this analysis suggests a common step in the signaling pathways that trigger I kappaB alpha, I kappaB beta, and I kappaB epsilon <clueType>degradation</clueType>.</clue>
</event>
<event KT="Other" id="E50">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="A30"/>
<clue>In addition, this analysis suggests a common step in the signaling pathways that <clueType>trigger</clueType> I kappaB alpha, I kappaB beta, and I kappaB epsilon degradation.</clue>
</event>
<event KT="Other" id="E51">
<type class="Positive_regulation"/>
<theme idref="E46"/>
<cause idref="A30"/>
<clue>In addition, this analysis suggests a common step in the signaling pathways that <clueType>trigger</clueType> I kappaB alpha, I kappaB beta, and I kappaB epsilon degradation.</clue>
</event>
<event KT="Other" id="E52">
<type class="Positive_regulation"/>
<theme idref="E47"/>
<cause idref="A30"/>
<clue>In addition, this analysis suggests a common step in the signaling pathways that <clueType>trigger</clueType> I kappaB alpha, I kappaB beta, and I kappaB epsilon degradation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
